Хаим Даненберг

Научные публикации

• Incidence and predictors of target lesion failure in patients with lesions in small vessels undergoing PCI with contemporary drug-eluting stents: Insights from the BIONICS study
• Pulmonary artery pressures and outcomes after MitraClip
• First-in-Human Transcatheter Tricuspid Valve Repair: 30-Day Follow-Up Experience With the Mistral Device
• Acute kidney injury after MitraClip implantation in patients with severe mitral regurgitation
• Pay Attention on the Road: TAVR and Vascular Complications
• Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients
• Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement
• LONG TERM FOLLOW-UP OF TRANSCATHETER SELF EXPANDABLE AORTIC VALVE IMPLANTATION
• The Use of Adenosine to Enable Safe Implantation of Transcatheter Tricuspid Valve
• The Prognostic Effects of Coronary Disease Severity and Completeness of Revascularization on Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement
• The role of monocyte subpopulations in vascular injury following partial and transient depletion
• Matched Comparison of Self-Expanding Transcatheter Heart Valves for the Treatment of Failed Aortic Surgical Bioprosthesis: Insights From the Valve-in-Valve International Data Registry (VIVID)
• Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials
• Pericardial covered stent for coronary perforations
• Depth of valve implantation, conduction disturbances and pacemaker implantation with CoreValve and CoreValve Accutrak system for Transcatheter Aortic Valve Implantation, a multi-center study
• Acute aortic regurgitation and hemodynamic collapse after balloon aortic valvuloplasty
• Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance
• C-reactive protein and atherothrombosis: Cause or effect?
• Strategies for multivessel revascularization in patients with diabetes
• Role of thromboxane receptor in C-reactive protein-induced thrombosis
• Stroke complicating transcatheter aortic valve implantation: incidence, risk factors and outcome
• Structure--activity relationship and preclinical evaluation of carbon-11-labeled ammonium salts as PET--myocardial perfusion imaging agents
• Allergic reaction to prasugrel and cross-reactivity with clopidogrel
• Endothelial C-reactive protein increases platelet adhesion under flow conditions
• Suppression of FoxO1 activity by long-chain fatty acyl analogs
• The role of 3-D CT angiography reconstruction in the diagnosis of vascular closure device complications
• Prior bare metal stent restenosis as a predictor for subsequent restenosis: the lightning often strikes twice
• Highlights from the Innovations in Cardiovascular Interventions Meeting: in favor of creativity and ingenuity
• Liposomal simvastatin attenuates neointimal hyperplasia in rats
• Stent thrombosis: a poor man's disease?
• Dabigatran versus warfarin in patients with atrial fibrillation
• Aspirin reduces the prothrombotic activity of C-reactive protein
• Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model
• Preparation of alendronate liposomes for enhanced stability and bioactivity: in vitro and in vivo characterization
• A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles
• Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes
• Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity
• "Inverted Tako-Tsubo": transient apical-sparing cardiomyopathy
• Uraemic hyperparathyroidism causes a reversible inflammatory process of aortic valve calcification in rats
• Neointimal formation is reduced after arterial injury in human crp transgenic mice
• C-reactive protein and atherothrombosis--a prognostic factor or a risk factor?
• Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy
• Sex hormones, soy, and myocardial injury
• Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge
• Raloxifene: cardiovascular considerations
• Very late coronary stent graft thrombosis after aspirin cessation
• Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice
• Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury
• C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy
• Nanospheres of a bisphosphonate attenuate intimal hyperplasia